Tag

Gray Market

All articles tagged with #gray market

Peptides craze meets caution: unregulated injections spark safety and regulatory questions
medicine-and-drugs13 days ago

Peptides craze meets caution: unregulated injections spark safety and regulatory questions

A wellness-driven surge in peptide injections touted for healing, recovery, and muscle-building rests on limited clinical evidence and carries safety risks. In 2023 the FDA banned production of several peptides by compounding pharmacies due to safety concerns and impurities, and the agency does not approve such compounds. US policy discussions about legalizing broader compounding could boost access but also risk, as product quality and dosing vary and most data come from animal studies. Experts urge caution and emphasize that rigorous human trials are still needed to establish true benefits and safety.

NYC's Slow Legal Weed Rollout Sparks Gray Market Cannabis Boom.
business3 years ago

NYC's Slow Legal Weed Rollout Sparks Gray Market Cannabis Boom.

The slow rollout of legal weed in the Tri-State area has led to the proliferation of "gray" market cannabis shops, with an estimated 1,400 illicit businesses in New York City alone. While state officials are trying to right the wrongs of the "War on Drugs" with social equity components in their recreational marijuana programs, anti-marijuana activists are trying to slow the fast pace of legal cannabis adoption. The national cannabis market is estimated to reach $71 billion in sales by 2030, with the New York state market alone potentially making up 10% of that.

Risks of Hormone Therapy from Unverified Online Sources for Trans Patients
health3 years ago

Risks of Hormone Therapy from Unverified Online Sources for Trans Patients

Transgender patients in the US are turning to unregulated foreign drug websites to access hormone therapy amid fears of bans in Republican states. The online marketplace, known as the gray market, is comprised of unregulated suppliers who sell legitimate medications, sometimes name-brand, outside the distribution channels authorized by the manufacturers. Doctors warn that self-administering hormones is "extraordinarily dangerous" because they can increase the risk of life-threatening blood clots, and there are no guarantees the drugs are legitimate. Missouri has issued a first-of-its-kind emergency rule that said adults must have had gender dysphoria for three years and received at least 18 months of therapy before receiving the drugs.